DYRK1A interacts with HBV cccDNA. by Florentin Pastor (19852287)

Subjects:

RNA levels of selected CMGC kinases in dHepaRG, PHHs and liver biopsies. by Florentin Pastor (19852287)

Subjects:

Longer polyQ sequences increase the tendency of AR to localize to nuclear puncta in the presence of DHT. by Carlos M. Roggero (11909585)

Subjects:

Longer polyQ sequences increase the tendency of AR-NTD to form gels. by Carlos M. Roggero (11909585)

Subjects:

Effect of single or combined DYRK1A/DYRK1B KD in HBV-infected PHHs. by Florentin Pastor (19852287)

Subjects:

BLB resistance assays for homozygous mutant rice lines L-5.7(-6), L-15.4(+1) and L-31.12(-3). by Phuong Nguyen Duy (11414117)

<b>Predictors of initial and sustained glycemic and weight response to tirzepatide: a post hoc analysis of SURPASS-4</b> by Ewan R. Pearson (157520)

“…<p dir="ltr">This post hoc analysis assessed sustainability of lowered HbA1c and weight with tirzepatide in people with type 2 diabetes and increased cardiovascular risk. …”

Correlations between volumetric decrease in rACC and average cortisol levels for patients (A) and controls (B) and correlations between volumetric decrease in rACC and the combined CTQ scales for physical and sexual abuse for patients (C) and controls (D). by Michael T. Treadway (371126)

“…<p>Correlations between volumetric decrease in rACC and average cortisol levels for patients (A) and controls (B) and correlations between volumetric decrease in rACC and the combined CTQ scales for physical and sexual abuse for patients (C) and controls (D).…”

Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”

Forest plot and volcano plot of ROR values (95% CI) for the first 30 high signal intensity AEs of penicillamine versus trientine. by Wenlong Qian (22608053)

Subjects:

SrbB is a transcriptional regulator of genes involved in carbon metabolism, lipid metabolism, and heme biosynthesis. by Dawoon Chung (655511)

A schematic summary of the experimental procedure. by Nicholas P. Carruth (16469743)

Loss of the Hypoxia Induced Transcriptional Regulator SrbB Results in a Significant Growth Defect and Red Pigmented Mycelia in Hypoxia. by Dawoon Chung (655511)

“…<p>(A). Growth of Δ<i>srbB</i> in normoxia and hypoxia on solid media. …”

Polymorphisms in <i>CYP1B1</i>, <i>CYP3A5</i>, <i>GSTT1</i>, and <i>SULT1A1</i> Are Associated with Early Age Acute Leukemia by Bruno Almeida Lopes (740876)

“…<i>CYP1B1</i> polymorphism was associated with a decreased risk of AML either for non-white or female children (additive model: OR = 0.24; 95% CI: 0.08–0.76, <i>p</i> < 0.01; additive model: aOR = 0.27; 95% CI: 0.08–0.89, <i>p</i> = 0.03, respectively). …”

Efficacy of istradefylline for gait disorders with freezing of gait in Parkinson’s disease: A single-arm, open-label, prospective, multicenter study by Mutsumi Iijima (6743459)

“…<p><b>Background</b>: Gait disorders are common in Parkinson’s disease patients who respond poorly to dopaminergic treatment. Blockade of adenosine A_2A receptors is expected to improve gait disorders. …”

The anatomy of a peer support interaction. by Molly L. Tolins (17319103)

Trends in Cystic Fibrosis Related Diabetes Epidemiology between 2003-2018 from the US Cystic Fibrosis Foundation Patient Registry by Celia L Kohler (21211119)

“…<p dir="ltr"><b>Objective</b>: A number of disease-modifying therapies have been introduced for people with cystic fibrosis (CF) over the past two decades. …”

Image 4_The immunomodulatory and antitumor properties of the bacterial metalloprotease Oligopeptidase A are mediated by TLR4/MyD88/TRIF and MAPK signaling pathways.tiff by Priscila Silva (556743)

“…</p>Results<p>Heat-inactivated OpdA significantly reduced metastasis, dependent on tumor-specific CD4+ and CD8+ T cells and IFN-γ, both locally and systemically, with decreased IL-10 levels suggesting a proinflammatory environment. …”

Image 2_The immunomodulatory and antitumor properties of the bacterial metalloprotease Oligopeptidase A are mediated by TLR4/MyD88/TRIF and MAPK signaling pathways.tiff by Priscila Silva (556743)

“…</p>Results<p>Heat-inactivated OpdA significantly reduced metastasis, dependent on tumor-specific CD4+ and CD8+ T cells and IFN-γ, both locally and systemically, with decreased IL-10 levels suggesting a proinflammatory environment. …”

Image 1_The immunomodulatory and antitumor properties of the bacterial metalloprotease Oligopeptidase A are mediated by TLR4/MyD88/TRIF and MAPK signaling pathways.tif by Priscila Silva (556743)

“…</p>Results<p>Heat-inactivated OpdA significantly reduced metastasis, dependent on tumor-specific CD4+ and CD8+ T cells and IFN-γ, both locally and systemically, with decreased IL-10 levels suggesting a proinflammatory environment. …”